GeneDx Holdings Corp. (WGS) Operating income 2019–2025
GeneDx Holdings Corp. (WGS) annual operating income history from SEC filings — each fiscal year as reported.
-$13.1MFY2025 · since FY2019: -$30.4M → -$13.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.1M | +43.7% |
| FY2024 | -$23.2M | +87.1% |
| FY2023 | -$180.6M | +73.0% |
| FY2022 | -$667.7M | -49.6% |
| FY2021 | -$446.1M | -84.4% |
| FY2020 | -$242.0M | -695.7% |
| FY2019 | -$30.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice